What does this research mean for the field?

The methodological quality of randomized control trials for early breast cancer treatment is moderate, with frequent deficiencies in randomization, withdrawal handling, and reporting, though quality improves over time and with the involvement of a biostatistician. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

June 1, 1986Journal of Clinical Oncology

A quality assessment of randomized control trials of primary treatment of breast cancer.

View Full Paper

Ask AI

Bookmark

Authors

ALA. LiberatiUniversity of Modena and Reggio Emilia HHHarvey N. HimelUniversity of Southern California TCT. C. ChalmersNational Institutes of Health Clinical Center

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liberati et al. (1986) studied this question.

synapsesocial.com/papers/6a0d53f088250cfcc2a4e097 https://doi.org/10.1200/jco.1986.4.6.942

View Full Paper

Ask AI

Bookmark

A quality assessment of randomized control trials of primary treatment of breast cancer.

Discussion

Member takes

Implication

Key Points

Cite This Study

A quality assessment of randomized control trials of primary treatment of breast cancer.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider